Evidence map›Paper›PMID 27051152›Full record

ArticleIndian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology

Bacteriological profile and antibiotic susceptibility patterns of clinical isolates in a tertiary care cancer center.

Vivek Bhat, Sudeep Gupta, Rohini Kelkar, Sanjay Biswas, Navin Khattry, Aliasgar Moiyadi, Prashant Bhat, Reshma Ambulkar, Preeti Chavan, Shubadha Chiplunkar and 2 more

Open access · diamondAbstract read
In one paragraph

Article in Indian journal of medical and paediatric oncology : official journal of Indian Society of Medical & Paediatric Oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Guidelines for Antibiotics Prescription in Critically Ill Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Indian Antimicrobial Prescription Guidelines in Critically Ill Immunocompromised Patients.Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine · 2019
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Vivek BhatACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Sudeep GuptaACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Rohini KelkarTMH, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Sanjay BiswasTMH, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Navin KhattryACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Aliasgar MoiyadiACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Prashant BhatACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Reshma AmbulkarACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Preeti ChavanACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Shubadha ChiplunkarACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Amol KotekarACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Tejpal GuptaACTREC, Tata Memorial Centre, Kharghar, Mumbai, Maharashtra, India.
Advanced Centre for Treatment, Research and Education in Cancer · INTata Memorial Hospital · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionThis increased risk of bacterial infections in the cancer patient is further compounded by the rising trends of antibiotic resistance in commonly implicated organisms. In the Indian setting this is particularly true in case of Gram negative bacilli such as Escherichia coli, Klebsiella pneumoniae and Acinetobacter spp. Increasing resistance among Gram positive organisms is also a matter of concern. The aim of this study was to document the common organisms isolated from bacterial infections in cancer patients and describe their antibiotic susceptibilities.

methodsWe conducted a 6 month study of all isolates from blood, urine, skin/soft tissue and respiratory samples of patients received from medical and surgical oncology units in our hospital. All samples were processed as per standard microbiology laboratory operating procedures. Isolates were identified to species level and susceptibility tests were performed as per Clinical Laboratory Standards Institute (CLSI) guidelines -2012.

resultsA total of 285 specimens from medical oncology (114) and surgical oncology services (171) were cultured. Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus aureus and Acinetobacter spp. were most commonly encountered. More than half of the Acinetobacter strains were resistant to carbapenems. Resistance in Klebsiella pneumoniae to cephalosporins, fluoroquinolones and carbapenems was >50%. Of the Staphylococcus aureus isolates 41.67% were methicillin resistant.

conclusionThere is, in general, a high level of antibiotic resistance among gram negative bacilli, particularly E. coli, Klebsiella pneumoniae and Acinetobacter spp. Resistance among Gram positives is not as acute, although the MRSA incidence is increasing.

Indexed as

Antibioticsresistancesusceptibility testing

Identifiers

PMID27051152
PMCPMC4795369
OpenAlexW2274785265

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.